SCHEMBL9989024

SCHEMBL9989024

CC1CCN(c2ncc3c(n2)CCCC3)CCN1C(=O)c1ccccc1-n1nccn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 20/20 1.00
HCRTR1 O43613 9/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1653365 1.00 HCRTR2 (1.00) HCRTR2HCRTR1
SCHEMBL1820795 1.00 HCRTR2 (1.00) HCRTR2HCRTR1
SCHEMBL1654845 0.98 HCRTR2 (0.97) HCRTR2HCRTR1
SCHEMBL1819916 0.98 HCRTR2 (0.97) HCRTR2HCRTR1
SCHEMBL1654954 0.89 HCRTR2 (0.80) HCRTR2HCRTR1
SCHEMBL1818223 0.89 HCRTR2 (0.80) HCRTR2HCRTR1
SCHEMBL1818875 0.87 HCRTR2 (0.77) HCRTR2HCRTR1
SCHEMBL1819664 0.87 HCRTR2 (0.77) HCRTR2HCRTR1
SCHEMBL5104493 0.85 HCRTR2 (0.75) HCRTR2HCRTR1
SCHEMBL2904888 0.84 HCRTR2 (1.00) HCRTR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2392572-A1 Substituted diazepan compounds as orexin receptor antagonists Merck Sharp & Dohme Corp. (US) 2011-12-07 EP claimed